JING LI
Massage Therapy in Flushing, NY
License number
Massachusetts 13802
Issued Date
May 26, 2016
Expiration Date
Aug 28, 2017
Type
Massage Therapist Practitioner
Address
Address
Flushing, NY 11354
Personal information
See more information about JING LI at radaris.comName
Address
Phone
4903 166Th St, Fresh Meadows, NY 11365
4831 203Rd St, Flushing, NY 11364
502 W 113Th St APT 3A, New York, NY 10025
472 44Th St, Brooklyn, NY 11220
4656 160Th St, Flushing, NY 11358
Professional information
Amplified Cancer Gene Wip1
US Patent:
2003003, Feb 13, 2003
Filed:
Feb 12, 2002
Appl. No.:
10/073123
Inventors:
Jing Li - Flushing NY, US
Scott Powers - Greenlawn NY, US
Scott Powers - Greenlawn NY, US
International Classification:
C12Q001/68, G06F019/00, A61K048/00
US Classification:
435/006000, 702/020000, 514/044000
Abstract:
There are disclosed methods and compositions for the diagnosis, prevention, and treatment of tumors and cancers in mammals, for example, humans, utilizing the WIP1 gene, which are amplified breast, and/or lung, and/or colon, and/or ovarian, and/or prostate cancer genes. The WIP1 gene, its expressed protein products and antibodies are used diagnostically or as targets for cancer therapy; they are also used to identify compounds and reagents useful in cancer diagnosis, prevention, and therapy.
Prc17: An Amplified Cancer Gene
US Patent:
2003004, Mar 6, 2003
Filed:
Feb 8, 2002
Appl. No.:
10/071838
Inventors:
Jing Li - Flushing NY, US
Scott Powers - Greenlawn NY, US
Phil Xiang - San Francisco CA, US
Yue Peng - South Setauket NY, US
Scott Powers - Greenlawn NY, US
Phil Xiang - San Francisco CA, US
Yue Peng - South Setauket NY, US
Assignee:
Tularik Inc. - South San Francisco CA
International Classification:
C12Q001/68, G01N033/574, C12P019/34
US Classification:
435/006000, 435/007230, 435/091200
Abstract:
The present invention provides nucleic acid and protein sequences for a novel protein, PRC17, and methods, reagents, and kits for diagnosing and treating cancer in a mammal, e.g., a human. This invention is based upon the discovery that the novel PRC17 is overexpressed and/or amplified in cancer. Methods to detect cancer or a propensity to develop cancer, to monitor the efficacy of a cancer treatment, and to treat cancer, by inhibiting the expression and/or activity of PRC17 in a cancer cell are included.
Amplified Gene Involved In Cancer
US Patent:
2003009, May 29, 2003
Filed:
Aug 27, 2002
Appl. No.:
10/228263
Inventors:
Jing Li - Flushing NY, US
International Classification:
C12Q001/68, G06F019/00, G01N033/48, G01N033/50, A61K048/00
US Classification:
435/006000, 702/020000, 514/044000
Abstract:
There are disclosed methods and compositions for the diagnosis, prevention, and treatment of tumors and cancers in mammals, for example, humans, utilizing the C8FW gene, which are amplified breast and/or brain and/or colon and/or lung and/or prostate and/or ovarian cancer genes. The C8FW gene, its expressed protein products and antibodies are used diagnostically or as targets for cancer therapy or vaccine; they are also used to identify compounds and reagents useful in cancer diagnosis, prevention, and therapy.
Gene Amplification In Cancer
US Patent:
2004000, Jan 8, 2004
Filed:
Mar 18, 2003
Appl. No.:
10/390191
Inventors:
Jing Li - Flushing NY, US
Scott Powers - Greenlawn NY, US
Jianxin Yang - Commack NY, US
Scott Powers - Greenlawn NY, US
Jianxin Yang - Commack NY, US
International Classification:
C12Q001/68, G01N033/574, C07H021/04, A61K048/00
US Classification:
435/006000, 514/044000, 536/023200, 435/007230
Abstract:
There are disclosed methods and compositions for the diagnosis, prevention, and treatment of tumors and cancers in mammals, for example, humans, utilizing the CTSZ and CD24 genes, which are amplified colon cancer and/or ovarian cancer and/or breast cancer genes. The CTSZ and CD24 genes, their expressed protein products and antibodies are used diagnostically or as targets for cancer therapy or vaccine; they also are used to identify compounds and reagents useful in cancer diagnosis, prevention, and therapy.
Amplification And Overexpression Of Oncogenes
US Patent:
2004000, Jan 8, 2004
Filed:
May 22, 2003
Appl. No.:
10/443108
Inventors:
Jing Li - Flushing NY, US
David Mu - Jericho NY, US
Jianxin Yang - Commack NY, US
David Mu - Jericho NY, US
Jianxin Yang - Commack NY, US
International Classification:
C12Q001/68, C07H021/04, C12P021/02, C12N005/06, A61K048/00, C07K014/705
US Classification:
435/006000, 435/069100, 435/320100, 435/325000, 530/350000, 514/044000, 536/023500
Abstract:
There are disclosed methods and compositions for the diagnosis, prevention, and treatment of tumors and cancers in mammals, for example, humans, utilizing the RecQL5, CTXL, USP13, MCL1, and Pellino1 genes, which are amplified in many types of cancer. The RecQL5, CTXL, USP13, MCL1, and Pellino1 genes, their expressed protein products and antibodies are used diagnostically or as targets for cancer therapy or as vaccines; they also are used to identify compounds and reagents useful in cancer diagnosis, prevention, and therapy.
Amplified Genes Involved In Cancer
US Patent:
2004017, Sep 2, 2004
Filed:
Nov 18, 2003
Appl. No.:
10/715117
Inventors:
Jing Li - Flushing NY, US
Scott Powers - Greenlawn NY, US
Wun Sin - Dix Hills NY, US
Jianxin Yang - Commack NY, US
Scott Powers - Greenlawn NY, US
Wun Sin - Dix Hills NY, US
Jianxin Yang - Commack NY, US
International Classification:
C12Q001/68, A61K048/00
US Classification:
435/006000, 514/044000
Abstract:
There are disclosed methods and compositions for the diagnosis, prevention, and treatment of tumors and cancers in mammals, for example, humans, utilizing genes, which are amplified in many types of cancer. The amplified genes, their expressed protein products and antibodies are used diagnostically or as targets for cancer therapy or as vaccines; they also are used to identify compounds and reagents useful in cancer diagnosis, prevention, and therapy.
Pee Spot
US Patent:
2012015, Jun 21, 2012
Filed:
Dec 20, 2010
Appl. No.:
12/928801
Inventors:
Jing Li - Flushing NY, US
International Classification:
A01K 29/00
US Classification:
119161
Abstract:
Training pad for housebreaking young dogs consisting of absorbent material imprinted with a circle which is impregnated with scented blue ink, contains SAP in the center, and backed by water impervious polyethylene which attracts young dogs to urinate only in the circle part of the pad.